Gerrit Voortman

898 total citations
26 papers, 695 citations indexed

About

Gerrit Voortman is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Reproductive Medicine. According to data from OpenAlex, Gerrit Voortman has authored 26 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Reproductive Medicine. Recurrent topics in Gerrit Voortman's work include Hormonal and reproductive studies (7 papers), Ovarian function and disorders (5 papers) and Reproductive Health and Contraception (4 papers). Gerrit Voortman is often cited by papers focused on Hormonal and reproductive studies (7 papers), Ovarian function and disorders (5 papers) and Reproductive Health and Contraception (4 papers). Gerrit Voortman collaborates with scholars based in Netherlands, United Kingdom and Denmark. Gerrit Voortman's co-authors include J.E. Paanakker, C. J. Timmer, Jan B. L. DAMM, R. de Leeuw, John W. M. Mulders, L. P. C. Delbressine, F. M. Kaspersen, R.M.E. Vos, Dan Apter and Marja­‐Liisa Dahl and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, American Journal of Obstetrics and Gynecology and Annals of Oncology.

In The Last Decade

Gerrit Voortman

26 papers receiving 639 citations

Peers

Gerrit Voortman
H C Porchet Switzerland
Polonca Ferk Slovenia
Tiedong Guo United States
Gaby Hofer Switzerland
A E Duncan United States
Laura Owen United Kingdom
A. Riondel Switzerland
Ashley M. Bunker United States
Gerrit Voortman
Citations per year, relative to Gerrit Voortman Gerrit Voortman (= 1×) peers Engin Yıldırım

Countries citing papers authored by Gerrit Voortman

Since Specialization
Citations

This map shows the geographic impact of Gerrit Voortman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Voortman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Voortman more than expected).

Fields of papers citing papers by Gerrit Voortman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Voortman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Voortman. The network helps show where Gerrit Voortman may publish in the future.

Co-authorship network of co-authors of Gerrit Voortman

This figure shows the co-authorship network connecting the top 25 collaborators of Gerrit Voortman. A scholar is included among the top collaborators of Gerrit Voortman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerrit Voortman. Gerrit Voortman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Jeffrey A., Anna N. Belova, Krzysztof Selmaj, et al.. (2015). Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis. JAMA Neurology. 72(12). 1433–1433. 59 indexed citations
2.
Reijers, Joannes A. A., et al.. (2014). A Phase I Dose-Escalation and Bioequivalence Study of a Trastuzumab Biosimilar in Healthy Male Volunteers. Clinical Drug Investigation. 34(12). 887–894. 26 indexed citations
3.
Hessels, Jan, et al.. (2003). Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer. Clinical Chemistry and Laboratory Medicine (CCLM). 41(1). 33–8. 14 indexed citations
4.
Bouloux, Pierre-Marc, Eberhard Nieschlag, Henry Burger, et al.. (2003). Induction of Spermatogenesis by Recombinant Follicle‐Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone. Journal of Andrology. 24(4). 604–611. 58 indexed citations
5.
Voortman, Gerrit, et al.. (2002). Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell. Clinical Chemistry and Laboratory Medicine (CCLM). 40(8). 795–8. 24 indexed citations
6.
Voortman, Gerrit, et al.. (2001). Follitropin-β administered by pen device has superior local tolerance compared with follitropin-α administered by conventional syringe. Reproductive BioMedicine Online. 3(3). 185–189. 17 indexed citations
8.
Voortman, Gerrit, Joseph Post, Rik C. Schoemaker, & Joop van Gerven. (1999). Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon®) by Pen-injector and syringe. Human Reproduction. 14(7). 1698–1702. 28 indexed citations
9.
Kaspersen, F. M., et al.. (1998). Pharmacokinetics and Biotransformation of Mirtazapine in Human Volunteers. Clinical Drug Investigation. 15(1). 45–55. 81 indexed citations
10.
Sneyd, J. Robert, et al.. (1997). Administration to humans of ORG 21465, a water soluble steroid i.v. anaesthetic agent. British Journal of Anaesthesia. 79(4). 427–432. 9 indexed citations
11.
Sneyd, J. Robert, Peter M. C. Wright, David L. Harris, et al.. (1997). Computer-controlled infusion of ORG 21465, a water soluble steroid i.v. anaesthetic agent, into human volunteers. British Journal of Anaesthesia. 79(4). 433–439. 11 indexed citations
12.
Dahl, Marja­‐Liisa, Gerrit Voortman, C. Alm, et al.. (1997). In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans. Clinical Drug Investigation. 13(1). 37–46. 67 indexed citations
13.
Leeuw, R. de, et al.. (1996). Recombinat hormones: Structure-function relationship of recombinant follicle stimulating hormone (Puregon®). Molecular Human Reproduction. 2(5). 361–369. 84 indexed citations
14.
Voortman, Gerrit & J.E. Paanakker. (1995). Bioavailability of mirtazapine from Remeron® tablets after single and multiple oral dosing. Human Psychopharmacology Clinical and Experimental. 10(S2). S83–S96. 44 indexed citations
15.
Geelen, J., et al.. (1993). Release kinetics of 3-keto-desogestrel from contraceptive implants (ImplanonR) in dogs: Comparison with in vitro data. Contraception. 47(2). 215–226. 8 indexed citations
16.
Timmer, C. J., Dan Apter, & Gerrit Voortman. (1990). Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings. Contraception. 42(6). 629–642. 24 indexed citations
17.
Voortman, Gerrit, et al.. (1990). Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. American Journal of Obstetrics and Gynecology. 163(6). 2132–2137. 33 indexed citations
18.
Möllmann, H, et al.. (1990). Pharmacokinetics of Rimexolone After Intra‐Articular Administration. The Journal of Clinical Pharmacology. 30(5). 476–479. 21 indexed citations
19.
Janssen, Frederik, et al.. (1987). Detection of wheat gluten, whey protein, casein, ovalbumin, and soy protein in heated meat products by electrophoresis, blotting, and immunoperoxidase staining. Journal of Agricultural and Food Chemistry. 35(4). 563–567. 17 indexed citations
20.
Hartigh, Jan den, Gerrit Voortman, W. J. van Oort, Hans van Weenen, & Herbert M. Pinedo. (1985). Handling of biological samples in the determination of the anti-neoplastic drug mitomycin C. Journal of Pharmaceutical and Biomedical Analysis. 3(5). 417–423. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026